A new set of monoclonal antibodies against human FcγRII (CD32) and FcγRIII (CD16): Characterization and use in various assays

Hybridoma

Volumn 16, Issue 6, 1997, Pages 519-528

  Vely, Frederic ^a,b   Gruel, Nadege ^a   Moncuit, Janine ^a   Cochet, Olivier ^a   Rouard, Helene ^a   Dare, Sophie ^a   Galon, Jerome ^a   Sautes, Catherine ^a   Fridman, Wolf Herman ^a   Teillaud, Jean Luc ^a  

^a INSTITUT CURIE   (France)

^b CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD32 ANTIGEN; FC RECEPTOR; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN KAPPA CHAIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2 B 2; MONOCLONAL ANTIBODY 3 D 3; MONOCLONAL ANTIBODY 6 C 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BINDING AFFINITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

ANIMALIA;

EID: 0031468105     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.1997.16.519     Document Type: Article

References (23)

1. Sautès C: Structure and expression of Fc receptors (FcR). In: Cell-mediated effects of immunoglobulins, Fridman WH and Sautès C (Eds.). Landes Bioscience, Austin, 1996, pp. 29-66 .
2. Hulett MD, and Hogarth M: Molecular basis of Fc receptor function. In: Advances in Immunology, vol. 57. Dixon, FJ (Ed.). Academic Press, San Diego, 1994, pp. 181-254.
3. de Haas M, Koene HR, Kleijer M, de Vries E, Simsek S, van Toi MJD, Roos D, and von dem Borne AEGKr: A triallelic Fey receptor type IIIA polymorphism influences the binding of human IgG by NK cell FcγRIIIa. J Immunol 1996;156:2948-2955.
4. Tamm A, and Schmidt RE: The binding epitopes of human CD16 (FcγRIII) monoclonal antibodies. J Immunol 1996;157:1576-1581.
5. van den Herik-Oudijk IE, Westerdaal NAC, de Haas M, Kemper L, Capel PJA, von dem Bonne AEGKr, and van de Winkel JGJ: Binding heterogeneity within the CD32 panel of mAb. In: Leukocyte typing V, White Cell Differentiation Antigens, Schlossman S, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder T, and Todd RF (eds.). Oxford University Press, Oxford, 1995, pp. 832-835.
6. Hibbs ML, Tolvanen M, and Carpen O: Membrane-proximal Ig-like domain of FcγRIII (CD16) contains residues critical for ligand binding. J Immunol 1994;152:4466-4474.
7. de Haas M, Kleijer M, Roos D, and von dem Borne AEGKr: Characterization of mAb of the CD16 cluster and six newly generated CD16 mAb. In: Leukocyte Typing V, White Cell Differentiation Antigens, Schlossman S, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder T, and Todd RF (Eds.). Oxford University Press, Oxford, 1994, pp. 811-814.
8. Teillaud JL, Bouchard C, Astier A, Tartour E, Michon J, Galinha A, Moncuit J, Mazieres N, Spagnoli R, Fridman WH, and Sautés C: Natural and recombinant soluble low affinity FcγR: Detection, purification and functional activities. Immunomethods 1994;4:48-64.
9. Huizinga TWJ, de Haas M, Kleijer M, Huijens JH, Roos D, and von dem Borne AEGKr: Soluble Fey receptor III in human plasma originates from release by neutrophils. J Clin Invest 1990;86:416-423.
10. de Haas M, Kleijer M, Michinton RM, Roos D, and von dem Borne AEGKr: Soluble FcγRIHa is present in plasma and is derived from Natural Killer cells. J Immunol 1994;152:900-907.
11. Gosselin EJ, Brown MF, Anderson CL, Zipf TF, and Guyre PM: The monoclonal antibody 41H16 detects the Leu-4 responder phenotype of human FcγRII. J Immunol 1990;144:1817-1822.
12. Weinrich V, Sondermann P, Bewarder N, Wissel K, and Frey J: Epitope mapping of new monoclonal antibodies recognizing distinct human FcRII (CD32) isoforms. Hybridoma 1996;15:109-116.
13. Warmerdam PAM, van de Winkel JGJ, Gosselin EJ, and Capel PJA: Molecular basis for a polymorphism of human Fey receptor II (CD32). J Exp Med 1990;172:19-25.
14. Rappaport EF, Cassel DL, Walterhouse DO, McKenzie SE, Surrey S, Keller MA, Schreiber AD, and Schwartz E: A soluble form of the Fc receptor FcγRIIA: Cloning, transcript analysis and detection. Exp Hematol 1993;21:689-696.
15. + cells. J Immunol 1994;152:201-212.
16. Astier A, de la Salle H, Freund M, Cazenave JP, Fridman WH, Hanau D, and Teillaud JL: Detection and quantification of secreted soluble FcγRIIA in human sera by an enzyme-linked immunosorbent assay. J Immunol Meth 1993;166:1-10.
17. Teillaud C, Galon J, Zilber MT, Mazières N, Spagnoli R, Kurrle R, Fridman WH, and Sautès C: Soluble CD16 binds peripheral blood mononuclear cells and inhibits pokeweed-mitogen-induced responses. Blood 1993;882:3081-3090.
18. Fazekas de St Groth S, and Scheidegger D: Production of monoclonal antibodies: Strategy and tactics. J Immunol Meth 1980;35:1-21.
19. Spira G, Bargellesi A, Teillaud JL, and Scharff MD: The identification of monoclonal class switch variants by Sib selection and an ELISA assay. J Immunol Meth 1984;74:307-315.
20. Hamada F, Aoki M, Akiyama T, and Toyoshima K: Association of immunoglobulin G Fc receptor II with src-like protein-tyrosine kinase Fgr in neutrophils. Proc Natl Acad Sci USA 1993;90:6305-6309.
21. Ierino FL, Hulett MD, McKenzie IFC, and Hogarth PM: Mapping epitopes of human FcγRII (CDw32) with monoclonal antibodies and recombinant receptors. J Immunol 1993;150:1794-1803.
22. Astier A, Merle-Beral H, de La Salle H, Moncuit J, Cazenave JP, Fridman WH, Hanau D, and Teillaud JL: Soluble Fey receptor, FcγRIIa2, is present in two forms in human serum and is increased in patients with stage C chronic lymphocytic leukemia. Leukemia and Lymphoma, 1997; 26:317-326.
23. 2. Blood 1995;85:698-704.